Analyst Research

Report Title Price
Provider: MarketLine (a Datamonitor Company)
$175.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Quest Diagnostics Inc Completes Sale of Enterix Business to Clinical Genomics of Australia


Tuesday, 1 Oct 2013 04:50pm EDT 

Quest Diagnostics Inc announced that on September 30, 2013 it completed the sale of its Enterix colorectal cancer screening test business to Clinical Genomics Technologies Pty Ltd., an Australian life sciences company. Terms of the transaction were not disclosed. 

Company Quote

62.32
0.08 +0.13%
2:00pm EDT